Vaccine News and Research

Latest Vaccine News and Research

CEL-SCI collaborates with UGA Center for Vaccines and Immunology to develop LEAPS COVID-19 immunotherapy

CEL-SCI Corporation announced today it has signed a collaboration agreement with the University of Georgia’s Center for Vaccines and Immunology to develop LEAPS COVID-19 immunotherapy.

23 Mar 2020

The COVID-19 vaccine pipeline

Major nations are in a race to make an effective vaccine that could help treat the novel coronavirus infection COVID-19. As hundreds of thousands are infected across the world and over sixteen thousand killed, the pandemic shows no signs of relenting.

23 Mar 2020

Lockdowns not enough to combat coronavirus, WHO warns

With more than 336,000 confirmed cases and at least 14,600 deaths across the globe, many countries and regions have imposed lockdowns in their territories to stem the spread of the coronavirus. The World Health Organization (WHO), however, says it is not enough.

23 Mar 2020

University of Queensland race to accelerate COVID-19 vaccine research

A funding injection of up to $17 million for vital University of Queensland research could help cut the timeline for an effective vaccine for COVID-19 by six months.

22 Mar 2020

World’s fastest supercomputer identifies chemicals with potential to stop COVID-19

What makes the coronavirus disease (COVID-19) global pandemic different from the Spanish flu in 1918? In 1918, transportation, technology, and science were in their infancy, with the medical field not capable of fighting outbreaks. Technology has come a long way, within days, scientists have already identified the type of virus spreading in China, and three months after, vaccine trials have started.

20 Mar 2020

Researchers highlight urgent need for public health leadership during COVID-19 pandemic

For decades, public health officials have directed the containment of emerging pandemics - perhaps most notably - the worldwide eradication of smallpox starting in the early to mid-1960s.

19 Mar 2020

Researchers invent portable AI device for flu and pandemic forecasting

University of Massachusetts Amherst researchers have invented a portable surveillance device powered by machine learning - called FluSense - which can detect coughing and crowd size in real time, then analyze the data to directly monitor flu-like illnesses and influenza trends.

19 Mar 2020

Research may pave the way to developing effective treatments for puerperal sepsis

Puerperal sepsis, also known as childbed fever, is the leading cause of maternal deaths. In this novel study in The American Journal of Pathology, published by Elsevier, scientists report on the discovery of group A streptococcus (GAS) surface proteins involved in female reproductive tract infections such as puerperal sepsis that may pave the way to developing vaccines and more effective treatments.

19 Mar 2020

Milken Institute launches vaccine development and treatment tracker for COVID-19

The Milken Institute is launching a resource to help the public and policymakers track progress in the development of treatments and vaccines for COVID-19.

19 Mar 2020

Researchers study how changing seasons will affect coronavirus spread

One of the biggest unknowns about the coronavirus is how changing seasons will affect its spread. Physicists from the University of Utah have received the university's first COVID-19-related grant to tackle the question.

18 Mar 2020

Strict measures to halt coronavirus spread will reduce deaths

Amid the coronavirus global pandemic, it is still unclear which government measures are useful in curbing the spread of the virus. Some countries had imposed lockdowns and community quarantines, while others took time to restrict population movement before they closed schools and nonessential businesses. Others are still allowing regular routines despite an increasing number of infections.

18 Mar 2020

Who should stay at home due to coronavirus?

COVID-19 is a spreading viral illness, mostly mild but fatal in the sick and elderly. At present, it has affected almost 200,000 people, with nearly 8,000 deaths worldwide. Governments around the world are formulating and executing new guidelines to control the spread of the virus. In the latest guidelines, pregnant women join the list of individuals who must stay away from all social contact for 12 weeks to limit the spread of the virus and deaths due to the illness.

17 Mar 2020

Vaxxas' novel high-density microarray patch can deliver vaccines safely and effectively

Vaxxas, a clinical-stage biotechnology company commercializing a novel vaccination platform, today announced the publication in the journal PLoS Medicine of groundbreaking clinical research indicating the broad immunological and commercial potential of Vaxxas' novel high-density microarray patch.

17 Mar 2020